ARGX - Argenx gets FDA approval for Vyvgart Hytrulo for CIPD
2024-06-21 17:11:38 ET
More on Argenx SE
- argenx SE (ARGX) Q1 2024 Earnings Call Transcript
- argenx: Innovation Over Losses In Autoimmune Arena
- argenx misses top-line and bottom-line estimates; updates FY24 outlook
- Argenx SE Q1 2024 Earnings Preview
- Seeking Alpha’s Quant Rating on Argenx SE